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ABSTRACT 
Early age of menarche (AOM) increases risk for chronic disorders, including cardiovascular 
disease and related mortality, type 2 diabetes, and breast cancer. Vitamin D deficiency may be 
linked to earlier onset of menstruation, but there is limited research examining vitamin D and its 
association with AOM. The objective of this study was to examine the association between 
vitamin D levels and AOM by analyzing the National Health and Nutrition Examination Survey 
(NHANES) data from 2001-2010. We hypothesized that that vitamin D deficiency is associated 
with earlier age of menarche in adolescent and early adult females in the United States. Cross-
sectional data on serum 25-hydroxy vitamin D (25OHD) levels and self-reported AOM were 
available on a sample of 3,572 females between the ages of 12-19 in the 2001-2010 NHANES. 
Multinomial logistic regression analysis was undertaken to estimate adjusted odds ratios (AORs) 
for the association between vitamin D status as reflected by serum 25OHD levels with both early 
(≤9 years) and late  (≥14 years) AOM, with adjustment for sampling design and controlling for 
potential confounders (race, body mass index [BMI], socio-economic status and age at time of 
participation). Girls with evidence of vitamin D deficiency (serum 25OHD <50nmol/L) were 
nearly twice as likely to report early AOM compared with the non-vitamin D deficient 
population (OR: 1.89; 95% CI 1.04-3.41). On multivariable analyses, however, this association 
between vitamin D deficiency and early AOM no longer held after controlling for age at 
interview, race/ethnicity, BMI, and poverty income ratio. Racial and BMI related predisposition 
to early AOM were evident. There was no interaction between vitamin D and the covariates of 
interest with the outcome AOM. Overall, in a representative sample of the US population, 
vitamin D status was not associated with AOM after adjusting for potential confounders.  
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BACKGROUND 
 
With adolescents in the United States reaching puberty at an earlier age, understanding 
factors that influence the onset of menstruation is critical in learning how to adjust pubertal 
timing (Chumela et al. 2003). According to existing research, most girls in the U.S. are 
menstruating by 13.8 years of age; with a median of 12.4 years, and only less than 10% reach 
menarche before age 11 (Chumela et al. 2003). Beyond the onset of sexual maturation, age of 
menarche (AOM) represents other characteristics of a population, including nutritional status and 
environmental factors (Chumela et al. 2003).  
Younger AOM has been shown to be associated with a number of adverse health 
outcomes, including increased risk of cardiovascular disease, cardiovascular disease mortality 
(Lakshman et al. 2009), overall mortality, ischemic heart disease, stroke mortality (Jacobsen et 
al. 2009), and type 2 diabetes (Lakshman et al. 2008; He et al. 2010). On the other hand, late 
AOM may also have adverse implications, particularly for bone health. During puberty, bone 
development is at its peak as the bones lengthen and accrues mineral deposition and gains in 
bone density (Gilsanz 2011). Women with later onset of menarche have demonstrated 
significantly decreased peak bone mass (Armamento-Villareal R et al. 1992), and bone mass and 
bone density at skeletal maturity exhibit an inverse relationship with pubertal timing in healthy 
adolescents (Gilsanz et al. 2011). Later AOM has also been associated with increased fracture 
risk (Cooper & Sandler 1997). It is thus important to understand modifiable factors that are 
associated with pubertal timing so as to optimize health in the adolescence period that may 
potentially promote the healthiest age for onset of menstruation.  
Although prior epidemiological studies have suggested an association between some 
lifestyle factors that are recognized to relate to vitamin D status (e.g. body mass, physical 
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activity) with AOM, the existing data have almost entirely focused on vitamin D-related 
variables, rather than vitamin D itself (Chew & Harris 2013). The only study that has directly 
examined a relationship between circulating vitamin D levels and AOM is a prospective cohort 
study of pre-menarcheal girls (n=242), conducted in Bogota, Columbia. The investigators found 
that girls with evidence of vitamin D deficiency (25OHD<50 nmol/L) were twice as likely to 
reach menarche during the observation period of 30 months compared with girls who were 
vitamin D sufficient (Villamor et al. 2011). Despite a burgeoning interest within the US in health 
implications of vitamin D in general, association between lifestyle factors and AOM in the US 
population remains hitherto unexplored.   
The purpose of this study therefore is to examine the association between vitamin D 
status, as reflected by serum levels of its metabolite 25-hydroxy vitamin D (25OHD), with AOM 
in adolescent and young reproductive age females in the United States, using a nationally 
representative population sample enrolled in the National Health and Nutrition Examination 
Survey (NHANES). Ours is the first study to examine an association between AOM and serum 
25OHD levels in the U.S. population.  
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METHODS 
Study Participants 
The National Center for Health Statistics of the Centers for Disease Control and 
Prevention (CDC) conducts the multistage, complex cluster design, cross-sectional NHANES 
survey each year to provide a nationally representative snapshot of the health and nutritional 
status of children and adults in the United States (CDC 2016). Comprehensive health information 
such as smoking habits, alcohol consumption, sexual practices, drug use, physical activity, 
weight, and dietary intake is collected on approximately 5,000 respondents each year. This 
information is analyzed to determine the prevalence and risk factors for chronic diseases in the 
United States. Information on demographics and health-related behaviors is collected during an 
initial interview in the participants’ homes. Following the interview, a physical examination is 
conducted in the Mobile Examination Center (MEC) to obtain physiological measurements and 
conduct a laboratory evaluation. 
Data from five waves of the NHANES survey for which information on laboratory values 
for vitamin D and information on reproductive health variables were available, 2001-2002, 2003-
2004, 2005-2006, 2007-2008, 2009-2010, were aggregately analyzed for this study. Data prior to 
2001 and after 2010 do not contain information for vitamin D, and reproductive health data are 
not publicly available for the most recent, 2013-2014, dataset. Low-income persons, adolescents 
12-19 years old, persons over 60 years of age, African Americans, and Mexican-Americans are 
oversampled in these survey cycles. Our analyses are restricted to females between ages 12 and 
19 years at the time of screening in an attempt to reduce potential for recall bias from inclusion 
of older populations, and to evaluate exposures closer to the AOM of survey respondents. 
Females were considered for inclusion in the study if they had already reached menarche, and 
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had complete information for AOM (n=4,075). Serum 25OHD laboratory values (nmol/L) were 
available for 3,572 (88%)  (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Study Sample Selection 
 
 
 
 
Assessed for eligibility (n=52,195) 
Excluded (n= 47,440) 
• Not female 
• Not in age range 12-19  
 
Participants meeting criteria 
(n=4,755) 
Data Available for Analysis       
(n= 4,075) 
Excluded (n=680) 
• Missing data for AOM 
• Did not know AOM 
• Had not reached menarche 
yet 
Excluded (n=503) 
• Missing 25OHD values 
 
Final Study Sample (n= 3,572) 
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Assessment of Vitamin D Status 
Vitamin D status can be reliably determined by serum 25OHD levels. Circulating 
25OHD primarily reflects endogenously synthesized vitamin D in the skin following sun 
exposure, with lesser contributions from the diet (Heaney 2011). Both vitamin D2, from plants, 
and vitamin D3, from animals, are represented in 25OHD values. In NHANES, serum 25OHD 
levels were assessed in participants aged one and older who were examined in the Mobile 
Examination Center (MEC). In accordance with the Endocrine Society’s classification, vitamin 
D status was categorized as follows: deficient (<50), insufficient (50-<75), and normal (≥75); for 
analyses, normal vitamin D status was taken as the referent group. For conversion from SI 
(nmol/L) units to conventional units (ng/ml), values were divided by 2.5. 
 
Assessment of Age of Menarche (AOM) 
All female participants aged 12 and older were asked the question, “How old were you 
when you had your first menstrual period?” Anyone who responded that they had not begun 
menstruating, did not know, or refused to answer the question was excluded from analysis. The 
AOM was available in whole numbers, ranging from 7 to 17. For analysis, AOM is categorized 
as: early (7-9 years), normal (10-13 years), and late (≥14 years); for analyses, normal AOM was 
taken as the referent group.  
 
Covariates 
Potential confounders for the relationship between AOM and vitamin D were identified 
from the literature and include: age at screening (continuous in years), race/ethnicity (non-
Hispanic white, non-Hispanic black, Mexican-American/other Hispanic, other), poverty income 
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ratio (PIR: ratio of income to the family’s appropriate poverty threshold, dichotomized as <1 for 
extreme poverty and ≥1 for above the poverty threshold), and BMI (continuous in kg/m2). Earlier 
studies concluded that non-Hispanic black and Mexican-American girls attained menarche at a 
significantly earlier age than non-Hispanic white girls, signifying that race is associated with our 
outcome of interest (Chumela et al. 2003). Race is also associated with our exposure of interest 
(vitamin D level), as vitamin D insufficiency is more prevalent among non-Hispanic blacks and 
Mexican-Americans as compared with Americans of other races and ethnicities (Harris 2006). 
Socioeconomic status has been found to be positively associated with both AOM and vitamin D 
levels (James-Todd et al. 2010; Weishaar & Vergili 2012) deeming its inclusion as a covariate in 
multivariable analyses. BMI was controlled for as it has been shown to exhibit an inverse 
relationship with both AOM (Al-Awadhi et al. 2013; Mohamad et al. 2013), and with serum 
25OHD levels (Lagunova et al. 2009).  
 
Data Analysis 
The analysis for this study proceeded in four steps. First, descriptive statistics were used 
to characterize the sample by categorized vitamin D status and AOM (Tables 1 and 2, 
respectively). Distribution for continuous variables (age, BMI, serum 25OHD level) was 
assessed and geometric means were computed using PROC SURVEYMEANS, while design-
adjusted chi-square analysis (PROC SURVEYFREQ) was used to calculate associations between 
categorical demographic factors (race and PIR) and AOM, and to assess differences in 
frequencies across categories of AOM (early, normal, and late) and of vitamin D status (normal, 
insufficiency, and deficiency). For unadjusted associations between categorized outcome 
variables and sample characteristics, a parametric analysis of variance (ANOVA) F-test was used 
for continuous variables, while the Pearson’s chi-square test for independence was used for 
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categorical variables. Second, multivariate linear regression was conducted with AOM and 
vitamin D as continuous variables to test for trend, using PROC SURVEYREG. Corresponding 
coefficients are discussed in the results.  
Third, to estimate adjusted and unadjusted odds ratios (OR) and corresponding 
confidence intervals for the magnitude of association between categorized AOM and vitamin D 
level, logistic regression analyses were conducted. PROC SURVEYLOGISTIC was used to 
determine whether vitamin D levels affected the probability of early or late AOM (normal AOM 
was taken as the referent group). A multinomial logistic regression compared the independent 
association of vitamin D status with AOM (early, normal, and late) after controlling for 
race/ethnicity, BMI, age at screening, and PIR. Table 4 shows results for the unadjusted 
regression, Table 5 lists OR for adjusted analyses. 
Lastly, to examine if any association between AOM and vitamin D was modified by 
BMI, race, or PIR, interaction terms of vitamin D and each of these covariates were included in 
separate logistic regression models. All analyses were conducted through survey procedures to 
account for the weighted sample in SAS 9.4 (SAS Institute, Cary, NC). To account for the 
complex survey design, non-response, oversampling, and post-stratification of NHANES, 
weights were incorporated to ensure that data is representative of the U.S. civilian non-
institutionalized population. As mentioned by the CDC’s National Health Center for Statistics 
(2013), the sample weight assigned to each sample person is a measure of the number of people 
in the population represented by that individual. As 10 survey years of NHANES were included 
in this analysis, a weight was constructed to combine weights across all five survey cycles, and 
thus all presented results are based on the weighted sample. Statistical significance was defined 
by an alpha of <0.05. 
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RESULTS 
Characteristics of the study sample by vitamin D status are presented in Table 1. The 
final study sample was composed of 3,572 adolescent and young adult females between the ages 
of 12 and 19 in the 2001-2010 NHANES. The mean age of the sample was 15.6±0.1 years, with 
mean BMI of 23.9±0.1 kg/m2; average AOM was 12.1 years. Approximately 31% of the 
population was vitamin D deficient; another 42% demonstrated vitamin D insufficiency, with the 
remaining 27% exhibiting normal vitamin D status. Vitamin D deficiency was greatest in non-
Hispanic blacks (38.0% vs. 25.1% in non-Hispanic whites and 28.2% in Mexican-Americans). 
Multivariate linear regression analyses showed no relationship between serum 25OHD levels 
with AOM (β=0.007, p<0.001). 
 
Age of Menarche (AOM) 
Table 2 presents characteristics of the study sample by categorical AOM.  In the 
weighted sample, early and late AOM was reported by 2.7% and 13.2% respectively. Serum 
25OHD levels were the lowest in the group reporting early AOM, and were the highest for those 
with late AOM   (p<0.001). The prevalence of vitamin D deficiency was highest amongst the 
early AOM and the lowest for the late AOM group (41.6% versus 24.3%, p<0.001); conversely, 
prevalence of normal vitamin D status was highest in the late AOM and least in the early AOM 
population (36.9% versus 18.2%, p<0.001). Table 4 presents results of multinomial univariate 
logistic regression analyses demonstrating associations between vitamin D and the covariates 
with AOM, presented as OR (95% CI).  On unadjusted analyses, females who were vitamin D 
deficient had nearly twice the odds of early AOM compared with those with normal levels of 
vitamin D (OR 1.89, 95% CI 1.04-3.41).  
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Racial and ethnic differential in AOM was noted.  Both Mexican-Americans and non-
Hispanic blacks were three times more likely to have experienced early AOM compared with 
non-Hispanic whites (Table 4), and the Mexican-American population was significantly less 
likely to experience late AOM compared with the Non-Hispanic whites. Each unit increase in 
BMI was associated with an 11% increased odds of early AOM (OR 1.11, 95% CI 1.08-1.14).  
Results from multivariable multinomial logistic regression analysis are presented in Table 
5.  The directionality of relationship between vitamin D deficiency and early AOM observed on 
univariate analyses (OR: 1.89, 95% CI 1.04-3.41) changed after controlling for age at screening, 
race/ethnicity, BMI, and PIR (OR: 0.69, 95% CI 0.28-1.70). There was no evidence of 
interaction between vitamin D and BMI, race, or PIR for the outcome of AOM.  
 
DISCUSSION 
Our analyses of vitamin D status and AOM among adolescents and young adult women 
identify BMI and race/ethnicity as independent predictors of AOM.  While individuals with 
evidence of vitamin D deficiency were significantly more likely to report early AOM, this 
relationship did not hold after controlling for BMI, race/ethnicity, SES and age at screening.  Our 
data therefore identify confounding influence of race/ethnicity and BMI for association between 
vitamin D status and AOM.  Relationship between higher BMI and early AOM is well described 
(Al-Awadhi et al. 2013; Mohamad et al. 2013) and this impression was corroborated in our 
study.  
The cross-sectional design of NHANES is a limitation that restricts our ability to 
establish causality and temporality of observed associations. Although AOM was self-reported, 
however, recall bias was minimized in our study by age restriction from 12 to 19 year olds. The 
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greatest strength of this analysis includes the use of NHANES, which incorporates a large 
sample size representative of the national population over a span of a decade. The only other 
study looking at vitamin D in relation to AOM is Villamor et al.’s prospective cohort study 
conducted in Bogota, Columbia, making our analysis the second to directly examine the 
association between vitamin D and AOM, and the first to incorporate a national sample of the 
U.S. Villamor et al.’s prospective cohort study (n=242) followed girls (mean age: 8.8±1.6 years) 
over 2.5 years and found that 57% of vitamin D deficient girls reached menarche during follow-
up compared with only 23% of those who were vitamin D sufficient. After adjusting for baseline 
age and BMI, investigators found that the probability of menarche for vitamin D deficient girls 
was two times higher than the probability for vitamin D sufficient girls (p=0.04).  
The difference between our null results and the outcomes of Villamor et al. may be 
attributed to racial and underlying genetic heterogeneity in the two populations. While 
categorization of AOM may have limited our study power to detect relationship between vitamin 
D deficiency with early and late AOM (given that only 2.7% and 13.2% of the sample reported 
early and late AOM respectively), we reexamined this association between vitamin D and AOM 
utilizing multivariable linear regression analysis that exhibited a similar non-statistically 
significant trend in relating lower vitamin D levels with earlier AOM result after adjustment for 
potential confounders (data not shown); thus small sample sizes in the extreme AOM groups are 
unlikely to explain the discrepancy between our results and those reported by Villamor et al. 
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CONCLUSION 
In a nationally representative sample of adolescent and early adult females of ages 
between 12 and 19 years from the 2001-2010 NHANES, vitamin D status at time of screening 
did not relate to AOM.  Although females who were vitamin D deficient (25OHD<50nmol/L) 
were more likely to report AOM at or before 9 years of age, this relationship disappeared after 
controlling for age at screening, race/ethnicity, BMI and SES. Future research on this subject 
should utilize a prospective approach, estimating both total and bioavailable 25OHD levels in the 
pediatric age predating onset of menses.  Regardless of the focus of interest (AOM in this case), 
the importance of sufficiency for both skeletal and non-skeletal targets for the adolescents and 
the early adults must be kept in perspective (Alsharani & Aljohani 2013) and strategies to 
optimize vitamin D status encouraged to prevent chronic health disorders such as osteoporosis.  
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Table 1.  Sample characteristics across vitamin D categories in 2001-2010 NHANES 
 
 
*Percentages are weighted based on the study sample
	  	   	   Vitamin	  D	  Level	   	  	   	  
Characteristic	  
	  
	  
	  
Total	  
Deficient	  	  
(<50	  nmol/L)	  	  
	  
	  
Insufficient,	  
(50-­‐<75	  
nmol/L)	  
	  
	   	  
Normal	  	  
(≥75	  nmol/L)	  
	  
pc	  
Total	   3572	   1768	  (31.0%)	   1269	  (41.7%)	   	   535	  (27.4%)	   	  
Age	  (years)	   15.6±0.1	   15.7±0.1	   15.3±0.1	   	   16.1±0.1	   0.012	  
Age	  of	  menarche	  (years)	   12.1±0.0	   11.9±0.0	   12.1±0.0	   	   12.4±0.1	   <0.001	  
Age	  of	  menarche	  (Row	  %)	   	   	   	   	   	   <0.001	  
	  	  	  	  	  Early	  (6-­‐9)	   129	  (2.7%)	   72	  (3.6%)	   43	  (2.6%)	   	   14	  (1.8%)	   	  
	  	  	  	  	  Normal	  (10-­‐13)	   3026	  (84.1%)	   1503	  (86.0%)	   1093	  (85.1%)	   	   430	  (80.4%)	   	  
	  	  	  	  	  Late	  (≥14)	   417	  (13.2%)	   193	  (10.3%)	   133	  (12.3%)	   	   91	  (17.8%)	   	  
Race/ethnicity	   	   	   	   	   	   <0.001	  
	  	  	  	  	  Non-­‐Hispanic	  white	   1019	  (61.2%)	   136	  (25.1%)	   479	  (68.0%)	   	   404	  (91.6%)	   	  
	  	  	  	  	  Non-­‐Hispanic	  black	   1067	  (14.6%)	   864	  (38.0%)	   181	  (6.0%)	   	   22	  (1.2%)	   	  
	  	  	  	  	  Mexican-­‐American/Other	  Hispanic	   1336	  (18.6%)	   688	  (28.2%)	   550	  (19.9%)	   	   98	  (5.8%)	   	  
	  	  	  	  	  Other	   150	  (5.7%)	   80	  (8.7%)	   59	  (6.1%)	   	   11	  (1.5%)	   	  
Annual	  household	  income	   	   	   	   	   	   <0.001	  
	  	  	  	  	  <$20,000	   727	  (11.7%)	   458	  (18.2%)	   211	  (10.0%)	   	   58	  (6.7%)	   	  
	  	  	  	  	  ≥$20,000	   1855	  (46.8%)	   879	  (43.1%)	   697	  (51.2%)	   	   279	  (44.1%)	   	  
	  	  	  	  	  Missing	   990	  (41.6%)	   431	  (38.6%)	   361	  (38.8%)	   	   198	  (49.2%)	   	  
Poverty	  income	  ratio	   	   	   	   	   	   <0.001	  
	  	  	  	  	  <1.0	   1288	  (26.4%)	   754	  (37.6%)	   397	  (21.8%)	   	   137	  (20.7%)	   	  
	  	  	  	  	  ≥1.0	   2284	  (73.6%)	   1014	  (62.4%)	   872	  (78.2%)	   	   398	  (79.3%)	   	  
Body	  mass	  index	  (kg/m2)	   23.9±0.1	   25.7±0.3	   23.4±0.2	   	   22.7±0.2	   <0.001	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Table 2. Sample characteristics across age of menarche categories in 2001-2010 NHANES 
 
 
*Percentages are based on the weighted study sample
	  	   	   Age	  of	  Menarche	   	   	  	  
Characteristic	  
Total	  	  
N	  (%)	  
Early	  	  
(6-­‐9	  years)	  	  
Normal	  
(10-­‐13	  years)	  	  
Late	  
(≥14	  years)	   pc	  
Total	   3572	   129	  (2.7%)	   3026	  (84.1%)	   417	  (13.2%)	   	  
Age	  (years)	   15.6±0.1	   15.8±0.2	   15.4±0.1	   17.2±0.1	   <0.001	  
Race/ethnicity	   	   	   	   	   <0.001	  
	  	  	  	  	  Non-­‐Hispanic	  white	   1019	  (61.2%)	   21	  (37.7%)	   845	  (60.5%)	   153	  (70.2%)	   	  
	  	  	  	  	  Non-­‐Hispanic	  black	   1067	  (14.6%)	   52	  (26.5%)	   888	  (14.4%)	   127	  (13.1%)	   	  
	  	  	  	  	  Mexican-­‐American/Other	  Hispanic	   1336	  (18.6%)	   50	  (31.9%)	   1163	  (19.1%)	   123	  (12.5%)	   	  
	  	  	  	  	  Other	   150	  (5.7%)	   6	  (4.0%)	   130	  (5.9%)	   14	  (4.2%)	   	  
Annual	  household	  income	   	   	   	   	   	  
	  	  	  	  	  <$20,000	   727	  (11.7%)	   31	  (13.0%)	   591	  (11.4%)	   105	  (13.1%)	   0.555	  
	  	  	  	  	  ≥$20,000	   1855	  (46.8%)	   60	  (40.5%)	   1599	  (47.6%)	   196	  (42.9%)	   	  
	  	  	  	  	  Missing	   990	  (41.6%)	   38	  (46.5%)	   836	  (41.0%)	   116	  (44.0%)	   	  
Poverty	  income	  ratio	   	   	   	   	   	  
	  	  	  	  	  <1.0	   1288	  (26.4%)	   56	  (36.6%)	   1060	  (25.6%)	   172	  (29.4%)	   0.138	  
	  	  	  	  	  ≥1.0	   2284	  (73.6%)	   73	  (63.4%)	   1966	  (74.4%)	   245	  (70.6%)	   	  
Body	  mass	  index	  (kg/m2)	   23.9±0.1	   28.8±0.8	   23.8±0.2	   23.6±0.4	   0.004	  
Vitamin	  D	  (nmol/L)	   63.6±1.0	   55.1±2.4	   62.9±1.0	   70.0±2.1	   <0.001	  
Vitamin	  D	  	   	   	   	   	   	  
	  	  	  	  	  Deficient	  (<50	  nmol/L)	   1768	  (31.0%)	   72	  (41.6%)	   1503	  (31.7%)	   193	  (24.3%)	   <0.001	  
	  	  	  	  	  Insufficient	  (50-­‐<75	  nmol/L)	   1269	  (41.7%)	   43	  (40.2%)	   1093	  (42.2%)	   133	  (38.8%)	   	  
	  	  	  	  	  Normal	  (≥75	  nmol/L)	   535	  (27.4%)	   14	  (18.2%)	   430	  (26.1%)	   91	  (36.9%)	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Characteristic 
Early (<9 years) Normal 
(10-13 years) 
Late (≥14 years) 
Vitamin D    
     Deficient (<50 nmol/L) 1.89** (1.04, 3.41) 1.00 0.54** (0.40, 0.74) 
     Insufficient (50-<75 nmol/L) 1.37 (0.76, 2.47) 1.00 0.65** (0.48, 0.89) 
     Normal (≥75 nmol/L) 1.00 1.00 1.00 
BMI (kg/m2) 1.11** (1.08, 1.14) 1.00 0.99 (0.96, 1.03) 
Race/ethnicity    
     Non-Hispanic white 1.00 1.00 1.00 
     Non-Hispanic black 2.95** (1.68, 5.17) 1.00 0.78 (0.58, 1.06) 
     Mexican-American 2.68** (1.31, 5.51) 1.00 0.56** (0.40, 0.78) 
     Other 1.07 (0.34, 3.42) 1.00 0.61 (0.28, 1.34) 
Age (years) 1.10 (0.99, 1.22) 1.00 1.61** (1.49, 1.74) 
Poverty income ratio    
     <1.0 1.68 (0.98, 2.88) 1.00 1.21 (0.85, 1.71) 
     >=1.0 1.00 1.00 1.00 
 
Table 3. Association of covariates and age of menarche (unadjusted), NHANES, 2001-2010 
 
** = significant at p<0.05 
 
 
 
 
 
Characteristic 
Early (<9 years) Normal 
(10-13 years) 
Late (≥14 years) 
Vitamin D    
     Deficient (<50 nmol/L) 0.69 (0.28, 1.70) 1.00 0.78 (0.49, 1.23) 
     Insufficient (50-<75 nmol/L) 1.09 (0.44, 2.71) 1.00 1.05 (0.71, 1.54) 
     Normal (≥75 nmol/L) 1.00 1.00 1.00 
BMI (kg/m2) 1.10** (1.07, 1.14) 1.00 0.97 (0.94, 1.00) 
Race/ethnicity    
     Non-Hispanic white 1.00 1.00 1.00 
     Non-Hispanic black 2.93** (1.45, 5.91) 1.00 1.05 (0.71, 1.55) 
     Mexican-American 2.95** (1.34, 6.51) 1.00 0.63** (0.44, 0.91) 
     Other 1.60 (0.49, 5.21) 1.00 0.71 (0.31, 1.64) 
Age (years) 1.02 (0.92, 1.14) 1.00 1.66** (1.52, 1.81) 
Poverty income ratio    
     <1.0 1.06 (0.62, 1.81) 1.00 0.93 (0.64, 1.36) 
     >=1.0 1.00 1.00 1.00 
 
 
Table 4. Association of covariates and age of menarche (adjusted), NHANES, 2001-2010 
 
Note: adjusted for vitamin D, race, age, BMI, PIR 
** = significant at p<0.05 
 
